Four parties. One connected system.
A patient support programme touches your team, the prescribing doctor, the patient and the pharmacy — and in Egypt, nothing connects them. Rubikcare is the network that does: doctors enrol in seconds, pharmacies verify every dispense, and your team sees enrolment, adherence and spend as it happens.
Call-centre model, on rubikcare
| Axis | Call-centre model | On rubikcare |
|---|---|---|
| Time to launch | 4–6 months per programme | Configured in minutes; first programme live in weeks, every next one same day |
| Cost structure | Fixed headcount, paid regardless of results | Performance-based — cost moves with dispensed value, not headcount |
| Enrolment | Paper forms, phone verification | In-app, under 60 seconds, at the point of prescription |
| Free goods | Paper vouchers, retrospective reconciliation | Single-use, patient-matched codes; anomaly detection |
| Reporting | Monthly slide deck | Live dashboard — enrolment, persistence, spend vs ceiling |
| Data compliance | Spreadsheets and messaging apps | PDPL-aligned by design, audit-ready |
| Scale ceiling | A few thousand patients | A 100,000-patient programme runs like a 1,000-patient one |
Model your brand's upside — before launch.
Enter your brand's numbers and see projected volume, revenue uplift and your break-even point.
Illustrative model based on the inputs above. Not a guarantee of results for any specific brand.
Based on published PSP literature: structured support programmes raise completion from 38% to 72%, and lift physician prescribing of supported therapies by 68%. Figures are illustrative — not a guarantee for any specific brand.
Physicians prefer supported therapies.
In published studies, physicians are more likely to prescribe a medicine that comes with a support programme — because they see better patient adherence.
That translates directly into prescribing uplift — before anything else begins.
Adherence is not a side effect. It is the revenue driver.
Published evidence from patient support programmes — showing how adherence translates into repeat revenue and therapy persistence.
Reduced abandonment of the first prescription — with cost assistance.
Reduced discontinuation — better therapy persistence.
Reduction in discontinuation — with lower total healthcare cost and fewer hospital visits.
of published studies showed significant adherence improvement for enrolled patients.
Published international evidence — establishes the mechanism. Results vary by therapy, programme, and brand. Not a guarantee for any specific brand.
Your first programme launches like your fiftieth.
-
Minutes
Programme design + configuration
-
Already live · nationwide
Pharmacy network
-
Hours
Field team briefing
-
Same day
First enrolled patient
Questions before you commit
It's yours. Full export, open formats, on request, at any time — contractually guaranteed. Tenant isolation means no other pharmaceutical company ever sees your programmes, prescribers or patients.